Home › NDC Lookup › RxCUI directory › RxCUI 997493

Fexofenadine hydrochloride 6 MG/ML Oral Suspension [Allegra] — RxCUI 997493

Name: Fexofenadine hydrochloride 6 MG/ML Oral Suspension [Allegra] (RxCUI 997493)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 997493 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI997493

Official nameFexofenadine hydrochloride 6 MG/ML Oral Suspension [Allegra]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asAllegra 6 MG/ML Oral Suspension; Allegra 30 MG in 5 mL Oral Suspension; Allegra 30 MG per 5 ML Oral Suspension

FDA products mapped2

Package NDCs mapped5

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fexofenadine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Fexofenadine is an antihistamine that relieves common allergy symptoms — things like a runny nose, sneezing, itchy or watery eyes, and an itchy nose or throat caused by hay fever o...
The FDA labels for fexofenadine do not list drowsiness as a side effect in the consumer sections provided. That said, everyone responds a little differently, so pay attention to ho...
You'll want to be careful here. The label says not to take fexofenadine at the same time as aluminum or magnesium antacids — the kind used for heartburn or upset stomach — and to a...
Can I take fexofenadine with my antacids or a glass of orange juice?

📖 Read our full Fexofenadine guide →

🕸️ Concept Web — How Fexofenadine hydrochloride 6 MG/ML Oral Suspensi... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Fexofenadine hydrochloride 6 MG/ML Oral Suspension [Allegra] RxCUI 997493 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Fexofenadine 87636 IN
- Fexofenadine hydrochloride 236474 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Allegra 324026 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Fexofenadine Oral Suspension 670106 SCDF
- Fexofenadine hydrochloride Oral Suspension 2647678 SCDFP
- Fexofenadine Oral Liquid Product 1165010 SCDG
- Fexofenadine Oral Product 1165011 SCDG
- Fexofenadine hydrochloride Oral Liquid Product 2660330 SCDGP
- Fexofenadine hydrochloride Oral Product 2662915 SCDGP
- Fexofenadine Oral Suspension [Allegra] 670109 SBDF
- Fexofenadine hydrochloride Oral Suspension [Allegra] 2657380 SBDFP
- +5 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Fexofenadine hydrochloride 6 MG/ML Oral Suspension 997491 SCD
- Fexofenadine hydrochloride 6 MG/ML 997490 SCDC
- Fexofenadine hydrochloride 6 MG/ML [Allegra] 997492 SBDC

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Fexofenadine hydrochloride 6 MG/ML Oral Suspension SCD · 997491
Fexofenadine hydrochloride 6 MG/ML SCDC · 997490
Fexofenadine Oral Suspension SCDF · 670106
Fexofenadine hydrochloride Oral Suspension SCDFP · 2647678
Fexofenadine Oral Liquid Product SCDG · 1165010
Fexofenadine Oral Product SCDG · 1165011
Fexofenadine hydrochloride Oral Liquid Product SCDGP · 2660330
Fexofenadine hydrochloride Oral Product SCDGP · 2662915

Brand-Name Concepts

Fexofenadine hydrochloride 6 MG/ML [Allegra] SBDC · 997492
Fexofenadine Oral Suspension [Allegra] SBDF · 670109
Fexofenadine hydrochloride Oral Suspension [Allegra] SBDFP · 2657380
Allegra Oral Liquid Product SBDG · 1166659
Allegra Oral Product SBDG · 1166660
Allegra BN · 324026

📦 FDA Products & Package NDCs

2 products · 5 package NDCs

5 package NDCs map to RxCUI 997493 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
41167-4244-01	1 BOTTLE in 1 CARTON (41167-4244-1) / 240 mL in 1 BOTTLE	Childrens Allegra Allergy	Chattem, Inc.	2011-03-03
41167-4244-04	1 BOTTLE in 1 CARTON (41167-4244-4) / 120 mL in 1 BOTTLE	Childrens Allegra Allergy	Chattem, Inc.	2011-03-03
41167-4244-07	3 BOTTLE in 1 CELLO PACK (41167-4244-7) / 120 mL in 1 BOTTL...	Childrens Allegra Allergy	Chattem, Inc.	2011-03-03
41167-4246-02	1 BOTTLE in 1 CARTON (41167-4246-2) / 240 mL in 1 BOTTLE	Childrens Allegra Allergy	Chattem, Inc.	2023-03-01
41167-4246-04	1 BOTTLE in 1 CARTON (41167-4246-4) / 120 mL in 1 BOTTLE	Childrens Allegra Allergy	Chattem, Inc.	2023-03-01

Observed labelers: Chattem, Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.